Free Trial

FINANCIALS: RBIAV: Belarusian Sale Signed But Regulators More Important

FINANCIALS

Raiffeisen (RBIAV: Baa2) has announced the signing of the deal to sell its Belarussian business. Should be a minor spread positive due to the simplification, but this remains subject to regulatory approvals, which is the key term, we feel. Until such approvals appear likely, we can’t see these tightening spreads and the process in Russia remains far more important overall.

  • RBI announced negotiations with Soven 1 Holdings in Feb-24 for the sale of Priorbank JSC, RBI’s business in Belarus. This is separate from its now-forlorn efforts to sell its business in Russia, which has come up against EU and US regulatory pressure and appears near-certain to fail.
  • The impact on RBI’s CET1 ratio is seen as 5bp negative on deal closure – no information is immediately available about the ongoing earnings/profitability impacts, but we expect these to be limited. This should be a minor spread positive on simplification.
  • However, “subject to regulatory approvals” remains the key phrase to us in the release. The sale of the business in Russia was at a similar stage when political pressure was brought to bear. Belarus is not Russia but appears aligned thereto, so the risk of failure here is relatively high, in our view.
198 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.

Raiffeisen (RBIAV: Baa2) has announced the signing of the deal to sell its Belarussian business. Should be a minor spread positive due to the simplification, but this remains subject to regulatory approvals, which is the key term, we feel. Until such approvals appear likely, we can’t see these tightening spreads and the process in Russia remains far more important overall.

  • RBI announced negotiations with Soven 1 Holdings in Feb-24 for the sale of Priorbank JSC, RBI’s business in Belarus. This is separate from its now-forlorn efforts to sell its business in Russia, which has come up against EU and US regulatory pressure and appears near-certain to fail.
  • The impact on RBI’s CET1 ratio is seen as 5bp negative on deal closure – no information is immediately available about the ongoing earnings/profitability impacts, but we expect these to be limited. This should be a minor spread positive on simplification.
  • However, “subject to regulatory approvals” remains the key phrase to us in the release. The sale of the business in Russia was at a similar stage when political pressure was brought to bear. Belarus is not Russia but appears aligned thereto, so the risk of failure here is relatively high, in our view.